Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,829 | Dovepress* | 8,324+ | 854 | 9,178 | |
| PubMed Central* | 505 | 155 | 660 | ||
| Totals | 8,829 | 1,009 | 9,838 | ||
| *Since 6 October 2017 | |||||
View citations on PubMed Central and Google Scholar